Imaging of Vitreous Opacities in a Canadian Population

Launched by PULSEMEDICA · Jan 3, 2024

Keywords

ClinConnect Summary

This clinical trial, titled "Imaging of Vitreous Opacities in a Canadian Population," is focused on studying eye floaters, which are small shapes or spots that can appear in your vision. The main goal of the trial is to create a collection of images of these floaters using a special eye imaging device. By doing this, researchers hope to learn more about floaters and how they affect people’s vision.

To participate, you need to be 18 years or older and experiencing noticeable floaters in your vision. However, if you have certain eye conditions, such as severe cataracts or specific types of glaucoma, you may not be eligible. If you decide to join the study, you will have your eyes imaged with the investigational device, which is a non-invasive process. This trial is currently recruiting participants of all genders, so if you're curious or think you might qualify, it could be a great opportunity to contribute to important research on eye health.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Aged 18 years or older
• • Symptomatic vitreous opacities (floaters) in vision
• • Clear ocular media, to allow a clear view of the vitreous for the SVO-ID
• Exclusion Criteria:
• • Younger than 18 years of age
• • Presence of vitreous hemorrhage
• • Cataract Grade 3 and above
• • Opacification of lens, cornea, or vitreous
• • Diagnosis of narrow angle glaucoma
• • Refractive error is outside the range of -6D to+3D
• • Astigmatism is outside the range of +/-2D of cylinder